5:15 PM ET
8-K
Shareholder Meeting
Pelthos Therapeutics Shareholder Meeting
Pelthos Therapeutics held its 2026 Annual Meeting of Stockholders where shareholders elected eight directors to serve until the 2027 meeting and ratified Grant Thornton LLP as the independent auditor for fiscal year 2026. Additionally, stockholders approved the 2026 Equity Incentive Plan, which replaces the company's previous 2023 plan.